ライフサイエンスコーパス: Philips

1 ssed at 12 mo by high-resolution ultrasound (Philips).

2 ned apical 2- and 4-chamber views (3DQ-QLAB, Philips).

3 dded into a handheld imaging device (Lumify; Philips).

4 , Siemens 1.5 T Avanto, Philips 3 T Ingenia, Philips 1.5 T Achieva.

5 With a Philips 1.5-T clinical NMR imaging/spectroscopic system,

6 ments was obtained with mDIXON Quant and the Philips 1.5-T unit (ICC, 0.995; 95% confidence interval

7 d: Siemens 3 T Prisma, Siemens 1.5 T Avanto, Philips 3 T Ingenia, Philips 1.5 T Achieva.

8 al [CI]: 0.991, 0.998), mDIXON Quant and the Philips 3.0-T unit (ICC, 0.992; 95% CI: 0.986, 0.996), a

9 Ultrasound images were acquired on a Philips 7500 system (Philips Medical Systems, Andover, M

10 In 31 patients, RT3DE data sets (Philips 7500) and long-axis CMR (Siemens, 1.5 T) and CCT

11 Echocardiographic imaging was performed (Philips 7500) in 21 patients referred for CMR imaging (1

12 RT3DE images obtained in 30 patients (Philips 7500) were analyzed by use of custom software ba

13 gered harmonic RT3DE datasets were acquired (Philips 7500) while infusion of Definity was initiated a

14 Examinations were performed using Philips Achieva 1.5T device, including spin echo and gra

15 ampectomy (SLAH) and were imaged using 3.0 T Philips Achieva MR scanner.

16 T (n = 15), GE Discovery ST PET/CT (n = 34), Philips Allegro PET (n = 5), and Philips Gemini PET/CT (

17 were studied using an Achieva MRI 3T device (Philips, Amsterdam, Netherlands).

18 stems from the three main manufacturers: GE, Philips and Siemens.

19 signal averages (NSA = 1-4, 15) at one 1.5-T Philips and three 3-T (Philips, Siemens and GE) scanners

20 US) was performed using an HDI-5000 scanner (Philips) and a finger-probe with pulse inversion harmoni

21 Foundation, Abbott, Yuhan Corp, CAH-Cordis, Philips, and Infraredx, a Nipro company.

22 dimensional US treatments (1.1-1.7 MI; iE33, Philips) applied intermittently whenever intravenously i

23 tified vendor (beta at 1.5 T = -4 msec [with Philips as reference], P < .001; beta at 3.0 T = -5 msec

24 were determined using 3-dimensional mapping (Philips Brilliance, Philips Medical Systems, Amsterdam,

25 to traditional stove/fuel combinations, the Philips burning wood or charcoal showed significant fuel

26 We present the Philips Critical Care Outcome Prediction Model (CCOPM) f

27 rage age was 56) performed on a 1.5T Achieva Philips device in the Provincial Hospital in Rzeszow bet

28 red by tele-ICU programs and recorded in the Philips eICU Research Institute database.

29 face plasmon resonance, and crystallography, Philips et al. explore the distinct features of PD-L2 an

30 ased global warming commitment (GWC) for the Philips FDCS were a factor of 8.6 and 2.8 times higher,

31 ectric (three of 48 studies), 0.92 +/- 0.03; Philips (four of 48 studies), 0.92 +/- 0.02; and Siemens

32 Both devices (the Philips FR2 or the HS1) are used in public access defibr

33 rers and endorectal coil (ERC) use (Siemens, Philips, GE with and without ERC, and the full dataset)-

34 T (n = 34), Philips Allegro PET (n = 5), and Philips Gemini PET/CT (n = 11)-were 0.99, 1.01, 1.00, 0.

35 ation following which MRI was carried out on Philips Gyroscan Achieva 1.5 Tesla unit.

36 we carried out an intervention utilizing the Philips HD4012 fan-assisted stove, one of the cleanest b

37 sions and efficiency of the Gyapa woodstove, Philips HD4012, threestone fire and coalpot (local charc

38 ic model, two forced-draft cookstoves (FDCS; Philips HD4012LS and ACE-1), and three institutional coo

39 phy of bilateral chest was performed using a Philips HD7 XE and a Sonoscape S2 portable ultrasound ma

40 nts.Measurements and Main Results: Using the Philips Health Care electronic ICU Research Institute Da

41 28 multi-detector (MDCT) CT scanners: - iCT (Philips Healthcare with iDose(4)); - Definitions AS+ (Si

42 graded to a continuous QT monitoring system (Philips Healthcare).

43 r Pancreatic Cancer Research, GE Healthcare, Philips Healthcare, and institutional funds from the Uni

44 de) were examined on a 3 T scanner (Elition, Philips Healthcare, Best, the Netherlands) and compared

45 ent imaging with one 1.5-T MR unit (Ingenia; Philips Healthcare, Best, the Netherlands) and two diffe

46 MRI was performed on a 3-T clinical scanner (Philips Healthcare, Best, The Netherlands).

47 scientific advisory boards of GE Healthcare, Philips Healthcare, Reflexion, and ImaginAb and is the o

48 y the MR imager manufacturers (mDIXON Quant [Philips Healthcare], IDEAL IQ [GE Healthcare]).

49 MDCT images were reconstructed using hybrid (Philips "iDose4") and model-based iterative (Philips "IM

50 A Philips iE33 echocardiographic module and X7-2t probe we

51 Philips "iDose4") and model-based iterative (Philips "IMR3") reconstruction algorithms.

52 cular magnetic resonance (CMR) scan on 1.5 T Philips Ingenia.

53 on (MC-SSS) algorithm implementations on the Philips Ingenuity TF PET/MR were used with 1 CT-based an

54 Image analysis was performed by the Philips Integris 3D RA device,which is a specialized wor

55 ted tomography perfusion (CTP) algorithms in Philips IntelliSpace Portal (v9, ISP) and to investigate

56 Ultrasound diagnosis was carried out using a Philips iU22 camera equipped with a linear probe with 17

57 ere obtained by epicardial scanning, using a Philips Medical Systems (Andover, Massachusetts) Sonos 7

58 ultidetector CT scanner (Ingenuity Core 128; Philips Medical Systems) to evaluate lung nodules and pu

59 ultidetector CT scanner (Ingenuity Core 128; Philips Medical Systems) to evaluate lung nodules and pu

60 graded off-line (Xcelera with QLAB software, Philips Medical Systems).

61 g 3-dimensional mapping (Philips Brilliance, Philips Medical Systems, Amsterdam, the Netherlands).

62 ages were acquired on a Philips 7500 system (Philips Medical Systems, Andover, Massachusetts) with a

63 d processing, a 3D-MTEE probe was developed (Philips Medical Systems, Andover, Massachusetts).

64 QXi, GE Healthcare, Milwaukee, Wis; MX8000, Philips Medical Systems, Best, the Netherlands; and Volu

65 to chest radiographs acquired using another (Philips), producing fake chest radiographs with differen

66 ocol for the D-shaped MA was developed using Philips Q-Laboratory mitral valve quantification softwar

67 All patients were examined on a 3 T MR Philips(R) scanner.

68 The women were scanned with a 1.5 T Philips scanner using a breath-hold multiecho gradient e

69 dults (age 12-28) were imaged using a 3T MRI Philips scanner.

70 1-4, 15) at one 1.5-T Philips and three 3-T (Philips, Siemens and GE) scanners.

71 on-weighted imaging) and scanner vendor (GE, Philips, Siemens) were performed, in addition to fairnes

72 ton thermometers on both the traditional and Philips stoves to collect continuous data on use pattern

73 ckinson, Boston Scientific, Cook, Medtronic, Philips, Surmodics, and TriReme Medical.

74 ographic examinations were performed using a Philips three-phase scanner installed at the Al- Razi Ho

75 ed of 1740 images obtained in 458 women with Philips US equipment.

76 The Philips was the only cookstove tested that showed signif

77 MRCP was performed in a 1.5-Tesla magnet (Philips) with SSH MRCP 3DHR and SSHMRCP rad protocol.

78 rs (EF; g (kg wood)(-1)) were lowest for the Philips, with statistically significant reductions relat

79 MCEs were significantly higher for Philips wood and charcoal-burning stoves compared to the